Novo Nordisk (NOVO.B DKK 876.70 CO) GLP-1 Evolutionary COMPANY OVERVIEW Headquartered in Bagsvrd, Denmark, Novo Nordisk develops and manufactures pharmaceutical products and services, with a focus on diabetes, obesity, and other serious chronic diseases including rare blood and endocrine diseases
Lam HM, Chiu J, Hsieh MH, Meisel L, Oliveira IC, Shin M, Coruzzi G (1998) Glutamate-receptor genes in plants
Exposure to GLP-1 RAs was consistently associated with significantly reduced odds of SUD cases
Activated FOXO1 upregulates pro-apoptotic genes like Bim and pro-atrophic genes such as MuRF1, contributing to cardiomyocyte death and atrophy
doi:10.1037/0033-2909.121.1.3 Campbell MK, DeVellis BM, Strecher VJ, Ammerman AS, DeVellis RF, Sandler RS
They help lower blood sugar, slow digestion and reduce appetite